AI in Predictive Toxicology Market Size & Growth Forecast 2027–2036, By Segments (Component, End User, Technology, Toxicity Endpoints), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growoth Outlook
AI in Predictive Toxicology Market size stood at USD 687.68 Million in 2026 and is predicted to grow at 30.09% CAGR from 2027 to 2036, surpassing USD 9.55 Billion by 2036. The industry revenue for 2027 is assessed at USD 870.26 Million.
Get more details on this report
Request Free Sample ReportAI in Predictive Toxicology Market Intelligence Snapshot
Regional Market Dynamics
- North America accounted for 46.64% in 2026, supported by advanced pharmaceutical ecosystems, sophisticated research infrastructure, datasets, and AI-life sciences expertise.
- Asia Pacific is expanding rapidly through greater pharmaceutical research, biotechnology investment, computational infrastructure, and adoption of AI across life sciences workflows.
Segment Momentum
- AI solutions accounted for 67.2% of the market in 2026 by enabling toxicity prediction, compound screening, risk assessment, and data analysis, helping organizations improve efficiency and accelerate safety evaluations.
- Contract research organizations are the fastest-growing end-user segment as they increasingly adopt AI-powered predictive toxicology tools to deliver efficient, data-driven preclinical research and safety evaluation services.
Market Expansion Drivers
- Rising investments in pharmaceutical AI startups accelerating predictive toxicology solution development pipelines
- Increased demand for efficient drug development accelerating AI-driven toxicity prediction integration
- Regulatory shift toward alternative testing methods boosting AI-based in-silico toxicology adoption
Leading Market Participants
- Prominent companies in the AI in predictive toxicology market include Exscientia plc (United Kingdom), Insilico Medicine (United States), Recursion Pharmaceuticals, Inc. (United States), BenevolentAI (United Kingdom), Atomwise Inc. (United States), Certara, Inc. (United States), Schrödinger, Inc. (United States), Simulations Plus, Inc. (United States), Optibrium Ltd. (United Kingdom), Instem plc (United Kingdom)
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 687.68 Million
- 2027 Estimated Market Size: USD 870.26 Million
- Projected Market Size: USD 9.55 Billion by 2036
- Growth Forecast: 30.09% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Solution (Component) | Pharmaceutical & Biotechnology Companies (End User) | Machine Learning (Technology) | Genotoxicity (Toxicity Endpoints)
- Emerging Opportunity Segment: Services (Component) | Contract Research Organizations (End User) | Natural Language Processing (Technology) | Genotoxicity (Toxicity Endpoints)
Market Growth Drivers and Industry Trends
Rising investments in pharmaceutical AI startups accelerating predictive toxicology solution development pipelines
Growing capital allocation toward emerging technology companies is strengthening innovation across the AI in predictive toxicology market by enabling the development of advanced solutions for toxicity assessment and compound evaluation. Investments in pharmaceutical AI startups are supporting research capabilities, algorithm refinement, and the expansion of predictive platforms designed to improve early-stage drug screening processes. These developments are encouraging collaboration between technology providers and life science organizations, allowing AI-based approaches to address complex challenges associated with conventional toxicology testing workflows.
Increased demand for efficient drug development accelerating AI-driven toxicity prediction integration
The need to reduce development complexities and improve research efficiency will drive the AI in predictive toxicology market growth as pharmaceutical organizations increasingly adopt artificial intelligence-based toxicity prediction tools. AI-driven systems help researchers analyze biological data, identify potential safety concerns earlier, and support more informed decisions during drug discovery. The integration of these technologies enables faster evaluation of candidate molecules while optimizing resource utilization across pharmaceutical development pipelines.
Regulatory shift toward alternative testing methods boosting AI-based in-silico toxicology adoption
Evolving regulatory preferences for innovative testing approaches are supporting wider acceptance of AI-enabled alternatives within the AI in predictive toxicology market. Regulatory movements encouraging the reduction of traditional testing methods are increasing interest in in-silico models that can simulate toxicity outcomes through computational analysis. This transition is motivating researchers and pharmaceutical organizations to incorporate artificial intelligence solutions that enhance predictive accuracy while supporting more efficient and technology-driven evaluation frameworks.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising investments in pharmaceutical AI startups accelerating predictive toxicology solution development pipelines | 3% | Low | North America, Europe | Emerging | Mid Term |
| Increased demand for efficient drug development accelerating AI-driven toxicity prediction integration | 3.2% | Moderate | North America, Europe, Asia Pacific | High | Near Term |
| Regulatory shift toward alternative testing methods boosting AI-based in-silico toxicology adoption | 2.6% | High | North America, Europe | Emerging | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
The AI in predictive toxicology market was led by North America, which accounted for 46.64% of the market in 2026, reflecting the region's advanced pharmaceutical and biotechnology ecosystem and strong adoption of computational approaches in drug development. Pharmaceutical companies and research institutions are increasingly using artificial intelligence to evaluate potential toxicity earlier in the development process, helping improve candidate selection and support more efficient preclinical assessment. The availability of sophisticated research infrastructure, extensive datasets, and expertise in AI and life sciences is supporting the integration of predictive models into toxicology workflows. In addition, the emphasis on improving drug safety and reducing development inefficiencies is creating favorable conditions for continued adoption of AI-driven toxicology tools.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is anticipated to register the fastest growth, supported by expanding pharmaceutical research capabilities, increasing investment in biotechnology, and growing adoption of artificial intelligence across healthcare and life sciences. The region's expanding drug development activity is creating greater demand for technologies that can improve the speed and efficiency of preclinical evaluation. Advances in computational research infrastructure and the increasing availability of biological and clinical data are also strengthening the potential applications of predictive toxicology. Furthermore, efforts to modernize pharmaceutical research, improve drug safety evaluation, and integrate digital technologies into laboratory workflows are expected to encourage wider use of AI-based toxicology solutions.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
United States 🇺🇸
Computational Safety ResearchThe U.S. advances AI in predictive toxicology through collaborations between pharmaceutical companies, biotechnology firms, and research organizations. Institutions in the U.S. increasingly integrate machine learning with toxicology datasets to improve early safety assessment and support drug development decisions.
Germany 🇩🇪
Data-Driven Risk AssessmentGermany emphasizes AI-enabled predictive toxicology by combining computational modeling with established pharmaceutical and chemical research capabilities. Organizations in Germany focus on improving toxicological screening efficiency while supporting alternative testing approaches and regulatory compliance.
Japan 🇯🇵
Precision Toxicology AnalyticsJapan applies AI in predictive toxicology to strengthen pharmaceutical research and chemical safety evaluations. Research institutions and life sciences companies in Japan increasingly use predictive models to identify toxicity signals earlier and optimize experimental validation strategies.
South Korea 🇰🇷
Bioinformatics-Led ScreeningSouth Korea integrates AI into predictive toxicology by leveraging bioinformatics expertise and expanding biomedical research capabilities. Companies in South Korea prioritize computational toxicity prediction to streamline candidate selection and improve research efficiency across life sciences programs.
France 🇫🇷
Regulatory Science SupportFrance promotes AI in predictive toxicology through research partnerships that strengthen chemical and pharmaceutical safety assessments. Organizations in France increasingly adopt predictive analytics to complement laboratory testing while aligning with evolving regulatory and scientific evaluation practices.
Italy 🇮🇹
Translational Safety ModelingItaly expands the application of AI in predictive toxicology across academic research and pharmaceutical development environments. Research teams in Italy increasingly employ computational toxicity models to improve early-stage safety evaluation and support more informed development decisions.
Segment Leadership and Growth Trends
AI in Predictive Toxicology Market Share (%), Component, 2025
Go beyond the chart, access full insights & data tables
Request Free Sample ReportComponent Segment Analysis: Solution (Largest Segment) vs Services (Fastest-Growing Segment)
Accounting for 67.2% of the AI in predictive toxicology market in 2026, the solution segment represented the largest share of the component category. The segment’s dominance is driven by growing adoption of AI-powered platforms that enable toxicity prediction, compound screening, risk assessment, and data analysis throughout the research and development process. These solutions help organizations improve efficiency, reduce dependence on traditional testing approaches, and accelerate decision-making in safety evaluations, making them a critical component of modern toxicology workflows.
The services segment is expected to record the fastest growth as organizations increasingly require specialized expertise to deploy, integrate, and optimize AI-driven toxicology tools. Demand for consulting, model validation, data management, and implementation support is rising as predictive toxicology applications become more sophisticated. The growing complexity of AI ecosystems and regulatory considerations is further strengthening the need for professional service offerings.
End User Segment Analysis: Pharmaceutical & Biotechnology Companies (Largest Segment) vs Contract Research Organizations (Fastest-Growing Segment)
The pharmaceutical and biotechnology companies segment held a 55.12% share of the AI in predictive toxicology market in 2026, making it the largest end-user category. These organizations are actively incorporating AI technologies into drug discovery and development processes to improve the identification of potential toxicity risks at earlier stages of research. The ability to enhance candidate selection, reduce development costs, and support more informed safety assessments continues to drive adoption among pharmaceutical and biotechnology companies.
Contract research organizations are projected to be the fastest-growing end-user segment as outsourcing trends gain momentum across the life sciences industry. These organizations are increasingly adopting AI-enabled predictive toxicology capabilities to deliver more efficient and data-driven research services to clients. Their expanding role in supporting preclinical studies and safety evaluations is contributing to accelerated demand for advanced predictive toxicology technologies.
Technology Segment Analysis: Machine Learning (Largest Segment) vs Natural Language Processing (Fastest-Growing Segment)
Machine learning emerged as the largest technology segment in 2026 due to its ability to analyze complex biological and chemical datasets, identify patterns, and generate predictive insights related to toxicity outcomes. The technology plays a central role in improving prediction accuracy, supporting compound evaluation, and enabling researchers to process large volumes of experimental and historical data more effectively. Its broad applicability across toxicology workflows has established machine learning as a foundational technology within the market.
Natural language processing is expected to be the fastest-growing technology segment as organizations seek to extract valuable insights from scientific literature, regulatory documents, clinical reports, and other unstructured data sources. By enabling automated information retrieval and knowledge discovery, natural language processing enhances research efficiency and supports more comprehensive toxicological assessments. Growing volumes of scientific data and increasing reliance on evidence-based decision-making are driving adoption of this technology.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Component | Solution, Services | Solution | Services |
| End User | Pharmaceutical & Biotechnology Companies, Chemical & Cosmetics, Contract Research Organizations, Others | Pharmaceutical & Biotechnology Companies | Contract Research Organizations |
| Technology | Machine Learning, Natural Language Processing, Computer Vision, Others | Machine Learning | Natural Language Processing |
| Toxicity Endpoints | Genotoxicity, Hepatotoxicity, Neurotoxicity, Cardiotoxicity, Others | Genotoxicity | Genotoxicity |
Competitive Landscape and Market Positioning
Major players in the AI in predictive toxicology market:
- Exscientia plc (United Kingdom)
- Insilico Medicine (United States)
- Recursion Pharmaceuticals, Inc. (United States)
- BenevolentAI (United Kingdom)
- Atomwise, Inc. (United States)
- Certara, Inc. (United States)
- Schrödinger, Inc. (United States)
- Simulations Plus, Inc. (United States)
- Optibrium Ltd. (United Kingdom)
- Instem plc (United Kingdom)
Scientific credibility is becoming the principal competitive battleground as developers seek to demonstrate that artificial intelligence can generate reliable toxicological insights across increasingly complex research and regulatory workflows. The emphasis has shifted from standalone predictive models to integrated platforms that combine diverse biological datasets, explainable analytics, and adaptable computational frameworks capable of supporting earlier decision-making in product development. Competitive momentum is increasingly favoring providers that can continuously refine model performance while ensuring transparency, interoperability, and regulatory readiness across evolving toxicology applications.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| No companies available. | |||||||
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Simulations Plus | Apr-26 | Simulations Plus initiated a multi-party collaboration with Lonza and the U.S. FDA to establish mechanistic predictive frameworks for amorphous solid dispersion drug products, leveraging advanced in vitro dissolution systems alongside GastroPlus and DDDPlus platforms to enhance early risk assessment and regulatory pathways. |
| DeepCyte | Apr-26 | DeepCyte secured $1.5 million in seed funding to launch operations, introducing the MetaCore single-cell metabolomics platform and the DeeImmuno AI solution to target toxicity mechanisms, improve biomarker identification, and address high financial losses stemming from clinical-trial failures. |
| Certara | Mar-26 | Certara rolled out Simcyp Simulator Version 25, an EMA-qualified physiologically based pharmacokinetic platform featuring expanded transporter-mediated drug-drug interaction modeling, enhanced biopharmaceutics capabilities, and integrated AI-enabled chat support to facilitate regulatory approvals and trial waivers. |
| Charles River Laboratories International, Inc. | Sep-23 | Charles River Laboratories International, Inc. partnered with Related Sciences to implement the Logica AI-driven drug discovery solution across unexamined targets within the RS portfolio, accelerating the translation of biological data into optimized preclinical assets. |
Explore This Report
Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.
AI in Predictive Toxicology Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| No segment data available. | |
AI in Predictive Toxicology Market — report.custom
| Custom Chapter | Custom Details | ||
|---|---|---|---|
| No custom TOC data available. | |||
Need a different cut of the data?
Request Custom ResearchWhat is the current size of the AI in predictive toxicology market?
What is the projected value of the AI in predictive toxicology industry by 2035?
How is AI improving efficiency in predictive toxicology and drug development?
Why are regulatory shifts supporting adoption of AI in predictive toxicology?
Why do AI solutions lead the AI in predictive toxicology market?
Which end-user segment is growing the fastest in the AI in predictive toxicology market?
What makes North America the leading market for AI in predictive toxicology?
Why is Asia Pacific emerging as a high-growth market for AI in predictive toxicology?
Who are the leading players in the AI in predictive toxicology landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source Category | Research Sources | Purpose |
|---|---|---|
| Government Publications | Government agencies, statistical departments, regulatory bodies | Industry statistics, regulatory insights, and policy analysis |
| Company Disclosures | Annual reports, investor presentations, financial filings | Company performance, business strategy, and market positioning |
| Trade Associations | Industry associations and professional organizations | Industry developments, standards, and market perspectives |
| Technical Literature | Research papers, technical publications, academic journals | Technology developments and technical validation |
| Patent Analysis | Patent databases and intellectual property publications | Innovation trends, technology activity, and competitive research |
| Industry Databases | Established research databases and market intelligence resources | Market benchmarking, historical data, and industry analysis |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization